ArticleRSC advances2026
Electronic reactivity and drug binding in doped cycloparaphenylenes: toward multifunctional platforms for biosensing and targeted drug delivery.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cycloparaphenylenes (CPP) and their heteroatom-doped derivatives are emerging as interesting nanocarriers due to their adjustable electronic structures and π-conjugated frameworks. This study used density functional theory (DFT) to examine the structural, electrical, and adsorption characteristics of virgin CPP, nitrogen-doped CPP (N-CPP), and oxygen-doped CPP (O-CPP) in relation to two anticancer agents, hydroxyurea (HU) and thioguanine (TG). Geometry optimization verified the inherent stability of all carriers, whereas doping induced localized distortions that increased reactivity. Electronic tests indicated a consistent decrease in the energy gap after medication adsorption. HU functioned as a weak electron donor, resulting in little gap narrowing, whereas TG operated as a robust electron acceptor, causing substantial band-gap quenching-particularly in TG@O-CPP, where the gap practically disappeared, resulting in metallic-like behavior. Adsorption energies (-0.10 to -1.13 eV) and recovery periods revealed divergent kinetics: HU complexes desorbed almost quickly, while TG demonstrated more robust binding and extended residence lengths, especially on O-CPP. Charge-transfer research validated the contrasting donor-acceptor functions of HU and TG, supported by global reactivity indices indicating heightened electrophilicity and reduced hardness upon TG adsorption. The findings identify TG@O-CPP as the most promising system, with improved adsorption strength, substantial charge transfer, notable band-gap reduction, and adjustable electrical responsiveness. These results provide significant insights for the systematic design of CPP-based nanostructures in biosensing applications that need rapid reaction and in drug-delivery systems that require controlled release.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.